v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities of continuing operations:    
Net loss $ (19,418,724) $ (15,047,412)
Adjustments to reconcile net loss to cash used in operating activities:    
Loss on extinguishment of debt 590,282
Stock issued for services 63,000 525,000
Options issued for services 765,792 2,000,919
Warrants issued for private placements fees 906,813 3,248,777
Depreciation and amortization 322,590 46,253
Loss on conversion of notes payable 10,420,182 2,355,868
Notes payable discount amortization 4,099,253 2,954,480
Derivative liability gain and loss (1,080,060)
Changes in operating assets and liabilities:    
Deferred revenue 24,413
Prepaid expenses (849) 15,210
ROU asset, net 23,339 (100,634)
Accounts payable and accrued expenses 132,527 462,205
ROU liabilities (21,576)
Interest payable 642,130 262,562
Net cash used in operating activities (2,530,888) (3,276,772)
Cash flows from investing activities:    
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from notes payable 2,418,750 3,100,000
Payment of notes payable (28,447)
Proceeds from the sale of common stock 136,477
Net cash provided by financing activities 2,390,303 3,236,477
Non-cash investing and financing activities:    
Net change in cash and cash equivalents (140,585) (40,295)
Cash, cash equivalents and restricted cash at beginning of period 2,023,072 396,870
Cash, cash equivalents and restricted cash at end of period 1,882,487 356,575
Supplemental disclosure of cash flow information:    
Acquisition of RMX Industries 29,943,876
Acquisition of intellectual property 3,652,350
Conversion of notes payable into common stock through warrant exercise 3,610,585 1,142,346
Conversion of notes (interest) 288,085
Conversion of notes (principal) $ 3,322,500